A New Era Begins for India’s Clinical Research Market
India’s participation in global clinical trials has nearly quintupled between 2001 and 2005, as investment in the country by large international and domestic pharmaceutical companies, small and medium-sized Western biotechs and the National Institutes of Health (NIH) has grown as well. The clinical research outsourcing market in India grew to $70.5 million last year and will continue to climb.
India’s business and regulatory climates have undergone dramatic change in the past 18 months through passage of a patent bill, regulations updated to harmonize with U.S. and international standards, and plans for a more FDA-like regulatory body. In CenterWatch’s July issue of The CenterWatch Monthly, we explore these issues, challenges and trends within India’s burgeoning clincical trials market landscape.
-To read this article, or any other CenterWatch stories, please click here.